Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Objective is to evaluate the pharmacokinetics profile of hydrocodone's metabolite
hydromorphone in patients who are taking hydrocodone on a routine basis for more than 3
months for chronic pain and correlate hydromorphone levels to their hydrocodone usage.
Phase:
Phase 4
Details
Lead Sponsor:
NEMA Research, Inc.
Collaborators:
International Clinical Research Institute Medtronic - MITG